Karanikas, V <br/><br/>
Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection.  [electronic resource] 

 -  Journal of immunotherapy (Hagerstown, Md. : 1997)   
 - 172-83 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-9557 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--immunology<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies--blood<br/>Breast Neoplasms--immunology<br/>Colonic Neoplasms--immunology<br/>Cyclophosphamide--administration & dosage<br/>Cytotoxicity, Immunologic<br/>Humans<br/>Hypersensitivity, Delayed<br/>Immunity, Cellular<br/>Immunotherapy, Active<br/>Injections, Intramuscular<br/>Injections, Intraperitoneal<br/>Lymphocyte Activation<br/>Mannans--administration & dosage<br/>Middle Aged<br/>Mucin-1--administration & dosage<br/>Neoplasms--immunology<br/>Recombinant Fusion Proteins--administration & dosage<br/>T-Lymphocytes--immunology